BE606331A - Tablette medicamenteuse à liberation retardee - Google Patents

Tablette medicamenteuse à liberation retardee

Info

Publication number
BE606331A
BE606331A BE606331A BE606331A BE606331A BE 606331 A BE606331 A BE 606331A BE 606331 A BE606331 A BE 606331A BE 606331 A BE606331 A BE 606331A BE 606331 A BE606331 A BE 606331A
Authority
BE
Belgium
Prior art keywords
delayed
release drug
drug tablet
tablet
release
Prior art date
Application number
BE606331A
Other languages
English (en)
Inventor
John Edward Wolff
William Robley Ebert
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of BE606331A publication Critical patent/BE606331A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
BE606331A 1960-07-19 1961-07-19 Tablette medicamenteuse à liberation retardee BE606331A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4374060A 1960-07-19 1960-07-19

Publications (1)

Publication Number Publication Date
BE606331A true BE606331A (fr) 1962-01-19

Family

ID=21928651

Family Applications (1)

Application Number Title Priority Date Filing Date
BE606331A BE606331A (fr) 1960-07-19 1961-07-19 Tablette medicamenteuse à liberation retardee

Country Status (3)

Country Link
BE (1) BE606331A (fr)
FR (1) FR1314M (fr)
GB (1) GB935672A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3413608A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
CN101669899B (zh) * 2009-09-29 2011-02-02 河北科技大学 玉米蛋白为主要骨架材料或基质的缓释埋植剂及其用途

Also Published As

Publication number Publication date
GB935672A (en) 1963-09-04
FR1314M (fr) 1962-05-14

Similar Documents

Publication Publication Date Title
BE619582A (fr) Tablettes thérapeutiques
AT282065B (de) Tablette
BE606331A (fr) Tablette medicamenteuse à liberation retardee
FR1281135A (fr) Tablette détergente
FR1346778A (fr) Tablette d'étalage
FR1244796A (fr) Distributeur à trois voies
FR1297897A (fr) Raccord à bague
FR1219340A (fr) Humidificateur saturateur à tablette
BE607505A (fr) Composés thérapeutiques à base de carbamate.
FR772M (fr) Médicament à base de composé d'azépine
BE582244R (fr) Transistoroscillator-oscillateur à transistor
FR2519M (fr) Médicament analgésique.
CA606009A (en) Pharmaceutical tablet
FR1765M (fr) Médicament anticryptogamique.
FR1242770A (fr) Transistor unipolaire à diffusion
FR663M (fr) Médicament à base de dithiosemicarbazones
FR274M (fr) Médicament antitussif.
FR1220741A (fr) Tablette d'allumage
BE612694A (fr) Médicament à base de beta-camphosulfonate de N-méthyléphédrine
FR1213835A (fr) Cendrier lumineux à pied
FR1257599A (fr) Trémie à capsules
FR282M (fr) Médicaments corticostéroides.
BE578077A (fr) Compositions pharmaceutiques
FR1237646A (fr) Ampoule à injection
FR319M (fr) Médicament sulfonamidé.